Approval · Notice of Compliance 2005 · 1999
RHOXAL-VALPROIC: Notice of Compliance 2005
Issued December 17, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2005
- Date
- December 17, 1999
- Company
- Rhoxalpharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- DEPAKENE (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RHOXAL-VALPROIC | 02239714 | Cancelled Post Market |
| RHOXAL-VALPROIC | 02239713 | Cancelled Post Market |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 500 MG per CAP